Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for action

Authors

Jay Epstein McLean, Virginia, United States of America

Yuyun Maryuningsih Blood and other Products of Human Origin Team, WHO headquarters, Geneva, Switzerland

Jean-Claude Faber Association Luxembourgeoise des Hémophiles, Luxembourg City, Luxembourg

W. Martin Smid Sanquin Consulting Services, Amsterdam and Academic Institute IDTM, Groningen, The Netherlands

Thierry Burnouf Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan; International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan